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Abstract
Purpose The schedule of attitudes toward hastened death
(SAHD) is widely used to assess the wish to hasten death
(WTHD) among patients with life-threatening conditions.
A short form of the SAHD would increase its clinical
applicability in this population.
Method Rasch analysis of data from 101 Spanish palliative
inpatients. Item reduction involved selecting items with a
high discrimination index (point-biserials C0.70), remov-
ing items with inadequate fit statistics, and assessing uni-
dimensionality and local dependency. We examined the
test probability function to establish an empirical risk score
for suffering a WTHD and tested convergence between the
original and the reduced set of items.
Results A set of five items met all quality criteria. In this
sample, 20.8 % of participants had a higher risk of a
WTHD (p[ 50 %) at a score of 3. Correlation analysis
confirmed convergent validity between the original and
reduced forms. Concurrent validity was confirmed by the
similar correlations shown by both versions of the SAHD
(5 and 20 items) with other measures.
Conclusion This 5-item Spanish form of the SAHD could
be a suitable alternative to the full instrument. The cut-off
score derived from the Rasch analysis may be able to detect
patients at risk of a WTHD.
Keywords Wish to hasten death  Desire to hasten death 
Desire to die  Palliative care  End-of-life care  End-of-life
decisions  Measurement  Instrument  Item response
theory
Introduction
The wish to hasten death (WTHD) is a reaction to a suffering
which can occur in patients with life-threatening conditions
[1, 2]. In the last two decades, several instruments have been
designed to measure the WTHD and to identify factors
related with it [3–6]. The most widely used instrument is the
schedule of attitudes toward hastened death (SAHD).
Developed by Rosenfeld et al. [7] the SAHD is a self-report
questionnaire with 20 items that respondents must rate as
true or false. The psychometric properties of the SAHD were
originally studied in North American samples involving
patients with AIDS [7] and palliative care (PC) cancer
patients [4]. The SAHD has been successfully adapted into
several languages [8–11], including Spanish [12].
The original version of this article was revised: The given name and
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Although the SAHD has become a well-established
instrument for research purposes [7] some of its charac-
teristics make it less suitable for use with patients who are
physically or emotionally fragile. For example, the task of
responding to 20 items may be exhausting for some
patients [10, 12, 13]. Furthermore, while a clinically
defined cut-off score for ‘‘high’’ desire to die has been
proposed previously [13], a score for predicting the risk of
a WTHD has yet to be established.
This study therefore had two aims: to develop a short
form of the Spanish SAHD and to define, for this short
form, a risk score for the WTHD in PC patients, using a
stochastic model based on scores from the SAHD.
Materials and methods
We conducted an item reduction study of the Spanish
version (SV) of the SAHD (SAHD-20 SV). Data came
from a previous cross-sectional study [12] in which a
convenience sample of 101 patients (62 male; Mage
61.7 ± 11 years, range 33–84) from a PC oncology unit in
Barcelona (Spain) completed the SAHD-20 SV. The sam-
ple is described in detail elsewhere [12].
Data analysis
We used a Rasch model to reduce the number of SAHD-20
SV items and to analyse whether the new set of items would
retain the information needed to detect a risk for the WTHD
in PC patients. The procedure involved three steps, in each
of which a Rasch analysis was carried out iteratively: (1)
after fitting data to the dichotomous Rasch model we
selected items with high discrimination values (point-bise-
rials C0.70). Point-biserials are Pearson’s product-moment
correlations between each item location and the mean Rasch
item estimation, excluding the item being analysed [14].
Higher values would correspond to a stronger WTHD con-
struct. (2) Items with fit statistics (Infit and Outfit) outside
the range 0.7–1.4 were examined and eventually removed.
These goodness-of-fit statistics indicate how accurately or
predictably the data fit the model [15]. (3) The person sep-
aration index—analogous to Cronbach’s alpha (reliabil-
ity)—and the unidimensionality assumption of the final set
of items were examined. A paired t test for the difference
between two sets of items identified by a residual-based
principal components analysis (PCAR) was made at the
person level; the percentage of these tests outside the range
of the 95 % confidence interval was not expected to exceed
5 %. If the Rasch quality criteria were satisfied, we exam-
ined the test probability function of the reduced set of items
to find a score that would indicate patients with a C50 %
risk of having a WTHD according to the new short version.
In addition, the strength of the relationship between the
reduced SAHD and the SAHD-20 SV was examined using
Pearson’s correlations. In order to assess correlations with
factors associated with the WTHD, we also examined the
correlations of both the reduced (SAHD-5 SV) and 20-item
versions of the SAHD with other instruments (all Spanish
versions): Karnofsky Performance Status (KPS) [16], where
higher scores [0–100] indicate a healthier status; the Barthel
Index (BI) [17], to assess the degree of independence in
activities of daily living (range 0–100, with higher scores
indicating greater independence); the Eastern Cooperative
Oncology Group Performance Status (ECOG-PS) [18]
(range 0–4, with higher scores indicating poorer function);
the Palliative care Outcome Scale (POS) [19], to assess
patients’ palliative needs (range 0–44, with higher scores
indicating greater needs); and the Hospital Anxiety and
Depression Scale (HADS) [20], to assess psychological
distress (range 0–21 for both anxiety (HADS-A) and
depression (HADS-D), with higher scores indicating levels
of anxiety or depression requiring specialist assessment).
Results
The first step of the reduction process showed that only
seven items had point-biserial correlations[0.70. Table 1
shows the correlations between item measures and the mean
Table 1 Correlations between item measures of the SAHD and the
mean Rasch item measure estimation





















Bold Values indicate, the items with point-biserial correlations[0.70
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Rasch item measures. In the second step (goodness-of-fit
analysis), two of these items (20 and 16) were removed as
their Infit and Outfit values were outside the established
range; inspection of these two items suggested that the most
likely cause of the misfit was the use of a double-barrelled
statement (item 20) and a threatening wording that might
drive participants to respond in a contrary way (item 16).
The five remaining items had adequate goodness-of-fit val-
ues. Table 2 shows the item location values of the final five
items and the goodness-of-fit statistics, as well as the two
items removed in each of the analyses. Reliability of the
final five-item scale was adequate (item separation index =
0.7). The percentage of individual t tests outside the range
±1.96 between items with positive and negative loadings
from the PCAR was optimal (\5 %), thus confirming the
hypothesis that the five items of the reduced scale (SAHD-5
SV) could be aligned on the same latent trait continuum.
Participants’ mean score on the SAHD-5 SV was -1.72
logits (SE = 0.21). Figure 1 shows a plot of the test char-
acteristic curve, or the sum of the item information func-
tions, representing the Rasch model prediction for each
measure relative to the WTHD when using the new SAHD-5
SV. The dashed lines indicate that the risk (C50 %) of
suffering a WTHD corresponds to patients who scored[2
on the SAHD-5 SV. Using this score and the SAHD-5 SV,
21 (20.8 %) participants had a risk of having a WTHD.
Correlation between the Rasch measures of the SAHD-5
SV and scores on the SAHD-20 SV was strong (r = 0.944,
p\ 0.01), and both versions of the SAHD (5 and 20 items)
produced similar correlations with the other measures
(Table 3).
Discussion
The results suggest that the proposed 5-item scale could be
a valid and reliable instrument for assessing and detecting
the risk of a WTHD. If so, the item reduction would confer
an important advantage when assessing the WTHD in the
most fragile patients.
The reduction process (similar to that used by Rosenfeld
et al. [21] in the recently published English short form)
drew attention to the possible influence of double-barrelled
wording on patients’ understanding of some SAHD-20 SV
items, the scores on which might therefore reflect two
issues rather than just one as intended. This aspect, not
highlighted in previous research [12], is likely due to the
fact that Rasch analysis is the most restrictive model within
IRT; other IRT models–such as 2PL or 3PL—might be less
restrictive and would fit these items. It should also be noted
that the psychometric properties of all other adaptations of
the SAHD were originally examined using methods
Table 2 Item location values of the final five items and the corresponding goodness-of-fit statistics (items are True/False in the schedule of






Final 4. I am seriously considering asking my doctor for help in ending my life. (True) 1.45 (0.53) 0.83 1.19
10. I hope my disease will progress rapidly because I would prefer to die rather than continue
living with this illness. (True)
0.24 (0.47) 0.79 0.87
12. I enjoy my present life, even with my illness, and would not consider ending it. (False) 0.24 (0.47) 1.24 1.23
13. Because my illness cannot be cured, I would prefer to die sooner, rather than later. (True) -0.63 (0.47) 0.96 1.23
14. Dying seems like the best way to relieve the emotional suffering my illness causes. (True) -1.29 (0.48) 1.02 0.85
2 20. I am able to cope with the symptoms of my illness and have no thoughts of ending my life. -1.04 (0.44) 1.5 1.44
1 16. Because of my illness, the idea of dying seems comforting. -2.86 (0.66) 1.00 1.95
a In brackets, true or false indicates the response that would indicate more desire for death
Table 3 Pearson coefficients for SAHD-5 SV and SAHD-20 SV [12]
in relation to the measures of performance status: Barthel Index [17],
Karnofsky Performance Status [16], and Eastern Cooperative
Oncology Group (ECOG) [18], Palliative Outcome Scale (POS)
[19], and Hospital Anxiety and Depression Scale (HADS) [20]
SAHD 20 item Barthel index ECOG Karnofsky POS HADS total HADS anxiety HADS depression
SAHD 5 items 0.944** -0.398** 0.311** -0.373** 0.499** 0.512** 0.259** 0.565**
SAHD 20 items 1 -0.400** 0.319** -0.403** 0.542** 0.514** 0.269** 0.559**
** p\ 0.01
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derived from classical test theory, which does not stress the
study of individual items, unlike the approach taken here.
Clearly, the item reduction entails a certain loss of
information. However, correlations with other instruments
used to assess patients’ physical and psychological status
were comparable for the Spanish SAHD-5 and SAHD-20
(see Table 3). Moreover, the SAHD-5 SV contains a fea-
sible number of items for obtaining the information needed
to assess the risk of a WTHD in clinical practice.
Assessment of the WTHD by means of the SAHD-5 SV
identified 20.8 % of patients as being at risk of a WTHD
(score[2), whereas the SAHD-20 SV [12] detected 16.8 %
of patients with a score considered ‘‘high’’ WTHD in the
literature. The short form thus appears to show increased
sensitivity for detecting the WTHD. Because Rasch anal-
ysis is a probabilistic model it allows us to estimate the
‘‘amount’’ of WTHD among participants. The usual crite-
rion in this context is that the probability or risk of pre-
senting a given construct is high if the respondent scores
C50 % on the measure used to assess that construct. This
approach contrasts with previous research in which labels
of ‘high’, ‘moderate’ or ‘low’ WTHD were established
clinically, without using a measurement model or subse-
quent verification. Our results therefore suggest that the
SAHD-5 SV might be useful for detecting the risk of a
WTHD in PC patients. Further research is, however, nec-
essary to evaluate the effectiveness of the instrument in
similar patient populations, to clarify criteria for labelling a
patient as experiencing a WTHD or not, and, thereafter, to
assess the sensitivity and specificity of the new instrument
using suitable methods (e.g. ROC curves).
This study has several limitations. One derives from the
nature and purpose of the SAHD-20 SV, which meant that
data were obtained from a relatively small convenience
sample consisting solely of cancer patients. The lack of a
gold standard for assessing the specificity and sensitivity of
the proposed short form is a further limitation. However,
data goodness of fit to the Rasch model was optimal.
Furthermore the use of the Rasch model allowed us to
convert discrete units into intervals, and thus the SAHD-5
SV could be used to study the sensitivity and specificity of
other instruments. Another limitation concerns the weak to
moderate correlation obtained for some of the scales that
assess physical status or daily function. Other scales that
examine psychological aspects such as meaning in life or
hopelessness would likely have been more appropriate
here.
By analysing the SAHD-20 SV at the item level, we
were able not only to produce a short form in Spanish but
also to identify some potential shortcomings in the original
SAHD. We therefore believe that our approach and results
will be of interest to researchers from other countries who
are seeking to adapt this instrument or to interpret their
own results, since the functioning of the SAHD is likely to
be influenced by cultural factors.
Conclusion
The SAHD-5 SV may constitute a valid and reliable
instrument for assessing and detecting the risk of the
WTHD. As such, it could contribute to the development of
more effective care plans for PC patients and be used as an
outcome measure of intervention studies.
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